Regidor PA - Search Results

1

Metabolic and laboratory effects of a progestin-only pill containing drospirenone 4 mg in comparison to desogestrel 75 µg: a double-blind, double-dummy, prospective, randomised study.

Palacios S, Colli E, Regidor PA. Palacios S, et al. Among authors: regidor pa. Eur J Contracept Reprod Health Care. 2021 Dec;26(6):454-461. doi: 10.1080/13625187.2021.1957094. Epub 2021 Aug 4. Eur J Contracept Reprod Health Care. 2021. PMID: 34348526 Free article. Clinical Trial.

2

Drospirenone as estrogen-free pill and hemostasis: coagulatory study results comparing a novel 4 mg formulation in a 24 + 4 cycle with desogestrel 75 μg per day.

Regidor PA, Colli E, Schindler AE. Regidor PA, et al. Gynecol Endocrinol. 2016 Sep;32(9):749-751. doi: 10.3109/09513590.2016.1161743. Epub 2016 Mar 30. Gynecol Endocrinol. 2016. PMID: 27028425 Free article.

3

The drospirenone (DRSP)-only pill: clinical implications in the daily use.

Kubba A, Gemzell-Danielsson K, Palacios S, Wiegratz I, Grandi G, Colli E, Regidor PA. Kubba A, et al. Among authors: regidor pa. Eur J Contracept Reprod Health Care. 2023 Feb;28(1):36-43. doi: 10.1080/13625187.2022.2164186. Eur J Contracept Reprod Health Care. 2023. PMID: 36724207 Free article. Review.

4

Pharmacological and metabolic effects of drospirenone as a progestin-only pill compared to combined formulations with estrogen.

Regidor PA, Mueller A, Mayr M. Regidor PA, et al. Womens Health (Lond). 2023 Jan-Dec;19:17455057221147388. doi: 10.1177/17455057221147388. Womens Health (Lond). 2023. PMID: 36744531 Free PMC article. Review.

5

The drospirenone only pill as a contraceptive option for breastfeeding women: First data on users' acceptability and newborn development.

Regidor PA, Colli E, Jakimiuk A. Regidor PA, et al. Gynecol Endocrinol. 2024 Dec;40(1):2382800. doi: 10.1080/09513590.2024.2382800. Epub 2024 Jul 29. Gynecol Endocrinol. 2024. PMID: 39069793 Free article.

6

A randomised double-blind trial to determine the bleeding profile of the prolonged-release contraceptive dienogest 2 mg/ethinylestradiol 0.02 mg versus an immediate-release formulation of drospirenone 3 mg/ethinylestradiol 0.02 mg.

Biskupska-Bodova K, Sójka-Kupny J, Nyirády T, Burke AE, Angulo A, Regidor PA. Biskupska-Bodova K, et al. Among authors: regidor pa. Eur J Contracept Reprod Health Care. 2024 Sep 16:1-10. doi: 10.1080/13625187.2024.2398433. Online ahead of print. Eur J Contracept Reprod Health Care. 2024. PMID: 39279689 Free article.

7

Level of c-erbB-2 oncoprotein in the homogenate of malignant and benign breast tumor samples.

Regidor PA, Callies R, Schindler AE. Regidor PA, et al. Eur J Gynaecol Oncol. 1995;16(2):130-7. Eur J Gynaecol Oncol. 1995. PMID: 7641740

8

Immunohistochemical detection of estrogen and progesterone receptors in endometriotic tissue. A comparative study of paraffin embedded and fresh frozen tissues.

Regidor PA, Regidor M, Metz KA, Schindler AE. Regidor PA, et al. Among authors: regidor m. Arch Gynecol Obstet. 1994;255(4):181-7. doi: 10.1007/BF02335083. Arch Gynecol Obstet. 1994. PMID: 7695364

9

[Granisetron, a new and potent antiemetic for treatment of cytostatic drug-induced vomiting in gynecological malignancies].

Regidor PA, Schindler AE. Regidor PA, et al. Geburtshilfe Frauenheilkd. 1994 Jan;54(1):51-4. doi: 10.1055/s-2007-1023550. Geburtshilfe Frauenheilkd. 1994. PMID: 8150251 German.

10

[Treatment of endometriosis with the GnRH analog triptorelin with special reference to the effect on bone density].

Regidor PA, Imberg C, Bühler K, Reiners C, Schindler AE. Regidor PA, et al. Zentralbl Gynakol. 1993;115(11):473-7. Zentralbl Gynakol. 1993. PMID: 8296491 German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

86 results

Search Page

Filters